• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structure of the human myostatin precursor and determinants of growth factor latency.人 MSTN 前体结构和生长因子潜伏的决定因素。
EMBO J. 2018 Feb 1;37(3):367-383. doi: 10.15252/embj.201797883. Epub 2018 Jan 12.
2
Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.类胶原裂解通过为前复合物的解离做准备来激活潜伏的 GDF8。
EMBO J. 2018 Feb 1;37(3):384-397. doi: 10.15252/embj.201797931. Epub 2018 Jan 17.
3
Structure and activation of pro-activin A.前活化素 A 的结构与激活。
Nat Commun. 2016 Jul 4;7:12052. doi: 10.1038/ncomms12052.
4
Structural basis of specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015.特异性抑制原肌球蛋白或潜伏肌抑素细胞外激活的单克隆抗体 SRK-015 的结构基础。
J Biol Chem. 2020 Apr 17;295(16):5404-5418. doi: 10.1074/jbc.RA119.012293. Epub 2020 Feb 19.
5
Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.卷曲螺旋结构域蛋白 2 follistatin 结构域的晶体结构揭示了其抑制生长分化因子 8(GDF8)和 GDF11 的机制。
J Biol Chem. 2019 Apr 19;294(16):6333-6343. doi: 10.1074/jbc.RA118.005831. Epub 2019 Feb 27.
6
Molecular characterization of latent GDF8 reveals mechanisms of activation.潜伏型 GDF8 的分子特征揭示了其激活机制。
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E866-E875. doi: 10.1073/pnas.1714622115. Epub 2018 Jan 18.
7
Latent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2.潜伏肌抑素具有显著的活性,这种活性受 WFIKKN1 的控制比受 WFIKKN2 的控制更有效。
FEBS J. 2013 Aug;280(16):3822-39. doi: 10.1111/febs.12377. Epub 2013 Jul 5.
8
Discovery of a follistatin-derived myostatin inhibitory peptide.发现一种来源于卵泡抑素的肌肉生长抑制素抑制肽。
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126892. doi: 10.1016/j.bmcl.2019.126892. Epub 2019 Dec 17.
9
Identification of a novel pool of extracellular pro-myostatin in skeletal muscle.骨骼肌中一种新型细胞外前肌肉生长抑制素的鉴定。
J Biol Chem. 2008 Mar 14;283(11):7027-35. doi: 10.1074/jbc.M706678200. Epub 2008 Jan 6.
10
The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.肌生成抑制蛋白前结构域的抑制核心:其与I型和II型膜受体的相互作用以及治疗肌肉萎缩的潜力。
PLoS One. 2015 Jul 30;10(7):e0133713. doi: 10.1371/journal.pone.0133713. eCollection 2015.

引用本文的文献

1
Characterization and Expression of TGF-β Proteins and Receptor in Sea Cucumber (): Insights into Potential Applications via Molecular Docking Predictions.海参中转化生长因子-β蛋白及受体的表征与表达:通过分子对接预测洞察潜在应用
Int J Mol Sci. 2025 Jul 21;26(14):6998. doi: 10.3390/ijms26146998.
2
Myostatin Modulation in Spinal Muscular Atrophy: A Systematic Review of Preclinical and Clinical Evidence.脊髓性肌萎缩症中的肌生成抑制素调节:临床前和临床证据的系统评价
Int J Mol Sci. 2025 Jun 18;26(12):5858. doi: 10.3390/ijms26125858.
3
Prodomain processing controls BMP-10 bioactivity and targeting to fibrillin-1 in latent conformation.前结构域加工控制BMP - 10的生物活性以及其在潜伏构象下与原纤维蛋白-1的靶向作用。
FASEB J. 2025 Feb 15;39(3):e70373. doi: 10.1096/fj.202401694R.
4
Yet another twist to the regulation of the TGF-β family ligands.转化生长因子-β家族配体的调控还有另一个转折。
Proc Natl Acad Sci U S A. 2025 Feb 11;122(6):e2426535122. doi: 10.1073/pnas.2426535122. Epub 2025 Feb 3.
5
A divergent two-domain structure of the anti-Müllerian hormone prodomain.抗苗勒管激素前结构域的一种不同的双结构域结构。
Proc Natl Acad Sci U S A. 2025 Jan 21;122(3):e2418088122. doi: 10.1073/pnas.2418088122. Epub 2025 Jan 13.
6
Bioinformatic approach to identifying causative missense polymorphisms in animal genomes.用于识别动物基因组中致病性错义多态性的生物信息学方法。
BMC Genomics. 2024 Dec 19;25(1):1226. doi: 10.1186/s12864-024-11126-z.
7
Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions.抑制肌肉生长抑制素以增加骨骼肌质量和功能的治疗应用及挑战。
Mol Cell Biochem. 2025 Mar;480(3):1535-1553. doi: 10.1007/s11010-024-05120-y. Epub 2024 Sep 28.
8
Structural Basis of Non-Latent Signaling by the Anti-Müllerian Hormone Procomplex.抗苗勒管激素前复合体的非潜伏信号传导的结构基础
bioRxiv. 2024 Apr 1:2024.04.01.587627. doi: 10.1101/2024.04.01.587627.
9
Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies.肌肉减少症的研究进展:机制、治疗靶点和干预策略。
Arch Pharm Res. 2024 Apr;47(4):301-324. doi: 10.1007/s12272-024-01493-2. Epub 2024 Apr 9.
10
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity.描述调控抗缪勒管激素合成和活性的分子机制。
FASEB J. 2024 Jan;38(1):e23377. doi: 10.1096/fj.202301335RR.

本文引用的文献

1
Molecular characterization of latent GDF8 reveals mechanisms of activation.潜伏型 GDF8 的分子特征揭示了其激活机制。
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E866-E875. doi: 10.1073/pnas.1714622115. Epub 2018 Jan 18.
2
Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.类胶原裂解通过为前复合物的解离做准备来激活潜伏的 GDF8。
EMBO J. 2018 Feb 1;37(3):384-397. doi: 10.15252/embj.201797931. Epub 2018 Jan 17.
3
A Prodomain Fragment from the Proteolytic Activation of Growth Differentiation Factor 11 Remains Associated with the Mature Growth Factor and Keeps It Soluble.生长分化因子11蛋白水解激活产生的前结构域片段与成熟生长因子保持结合并使其保持可溶状态。
Biochemistry. 2017 Aug 22;56(33):4405-4418. doi: 10.1021/acs.biochem.7b00302. Epub 2017 Aug 3.
4
Structural basis for potency differences between GDF8 and GDF11.生长分化因子8(GDF8)和生长分化因子11(GDF11)效力差异的结构基础。
BMC Biol. 2017 Mar 3;15(1):19. doi: 10.1186/s12915-017-0350-1.
5
Structural Basis for the Effective Myostatin Inhibition of the Mouse Myostatin Prodomain-Derived Minimum Peptide.小鼠肌生成抑制素前结构域衍生的最小肽有效抑制肌生成抑制素的结构基础。
ACS Med Chem Lett. 2016 Nov 23;8(1):113-117. doi: 10.1021/acsmedchemlett.6b00420. eCollection 2017 Jan 12.
6
Structural Biology and Evolution of the TGF-β Family.转化生长因子-β家族的结构生物学与进化
Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):a022103. doi: 10.1101/cshperspect.a022103.
7
Structure and activation of pro-activin A.前活化素 A 的结构与激活。
Nat Commun. 2016 Jul 4;7:12052. doi: 10.1038/ncomms12052.
8
Structure of bone morphogenetic protein 9 procomplex.骨形态发生蛋白9前复合体的结构
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):3710-5. doi: 10.1073/pnas.1501303112. Epub 2015 Mar 6.
9
Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin.在肌肉生长抑制素的生长与分化因子相关血清蛋白(GASP)家族拮抗作用中鉴定出的替代结合模式。
J Biol Chem. 2015 Mar 20;290(12):7506-16. doi: 10.1074/jbc.M114.624130. Epub 2015 Feb 5.
10
Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition.鉴定小鼠肌肉生长抑制素前结构域中对人肌肉生长抑制素具有抑制作用的最小肽段。
J Med Chem. 2015 Feb 12;58(3):1544-9. doi: 10.1021/jm501170d. Epub 2015 Jan 21.

人 MSTN 前体结构和生长因子潜伏的决定因素。

Structure of the human myostatin precursor and determinants of growth factor latency.

机构信息

Department of Biochemistry, University of Cambridge, Cambridge, UK.

Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA.

出版信息

EMBO J. 2018 Feb 1;37(3):367-383. doi: 10.15252/embj.201797883. Epub 2018 Jan 12.

DOI:10.15252/embj.201797883
PMID:29330193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5793801/
Abstract

Myostatin, a key regulator of muscle mass in vertebrates, is biosynthesised as a latent precursor in muscle and is activated by sequential proteolysis of the pro-domain. To investigate the molecular mechanism by which pro-myostatin remains latent, we have determined the structure of unprocessed pro-myostatin and analysed the properties of the protein in its different forms. Crystal structures and SAXS analyses show that pro-myostatin adopts an open, V-shaped structure with a domain-swapped arrangement. The pro-mature complex, after cleavage of the furin site, has significantly reduced activity compared with the mature growth factor and persists as a stable complex that is resistant to the natural antagonist follistatin. The latency appears to be conferred by a number of distinct features that collectively stabilise the interaction of the pro-domains with the mature growth factor, enabling a regulated stepwise activation process, distinct from the prototypical pro-TGF-β1. These results provide a basis for understanding the effect of missense mutations in pro-myostatin and pave the way for the design of novel myostatin inhibitors.

摘要

肌肉生长抑制素(Myostatin)是脊椎动物肌肉质量的关键调节因子,在肌肉中作为潜伏前体生物合成,并通过前导肽的顺序蛋白水解而被激活。为了研究前肌生长抑制素保持潜伏的分子机制,我们确定了未经处理的前肌生长抑制素的结构,并分析了其不同形式的蛋白质特性。晶体结构和 SAXS 分析表明,前肌生长抑制素采用开放的 V 形结构,具有域交换排列。弗林蛋白酶切割位点切割后,前成熟复合物与成熟生长因子相比,活性显著降低,并保持稳定的复合物状态,对天然拮抗剂卵泡抑素具有抗性。这种潜伏性似乎是由许多不同的特征赋予的,这些特征共同稳定了前域与成熟生长因子的相互作用,从而能够进行调节的逐步激活过程,与典型的前转化生长因子-β1 不同。这些结果为理解前肌生长抑制素中错义突变的影响提供了基础,并为设计新型肌生长抑制素抑制剂铺平了道路。